BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8813592)

  • 1. Partial agonist effects of BW A868C, a selective DP receptor antagonist, on Cl- secretion in dog tracheal epithelium.
    Liu YJ; Jackson DM; Blackham A; Leff P
    Eur J Pharmacol; 1996 May; 304(1-3):117-22. PubMed ID: 8813592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of BW A868C, a selective prostaglandin DP receptor antagonist, in dog isolated vascular preparations.
    Liu YJ; Jackson DM; Blackham A
    Eur J Pharmacol; 1996 May; 303(3):187-92. PubMed ID: 8813566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein.
    Lydford SJ; McKechnie KC; Leff P
    Prostaglandins; 1996 Aug; 52(2):125-39. PubMed ID: 8880898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.
    Giles H; Leff P; Bolofo ML; Kelly MG; Robertson AD
    Br J Pharmacol; 1989 Feb; 96(2):291-300. PubMed ID: 2924081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?
    Rangachari PK; Betti PA; Prior ET; Roberts LJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):611-7. PubMed ID: 7473146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of the prostanoid DP receptor in human myometrium.
    Fernandes B; Crankshaw D
    Eur J Pharmacol; 1995 Sep; 283(1-3):73-81. PubMed ID: 7498323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C.
    Hamid-Bloomfield S; Whittle BJ
    Br J Pharmacol; 1989 Feb; 96(2):307-12. PubMed ID: 2647205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
    Trist DG; Collins BA; Wood J; Kelly MG; Robertson AD
    Br J Pharmacol; 1989 Feb; 96(2):301-6. PubMed ID: 2466517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective prostaglandin D2 receptor stimulation elicits ocular hypotensive effects in rabbits and cats.
    Matsugi T; Kageyama M; Nishimura K; Giles H; Shirasawa E
    Eur J Pharmacol; 1995 Mar; 275(3):245-50. PubMed ID: 7768291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.
    Hamid-Bloomfield S; Payne AN; Petrovic AA; Whittle BJ
    Br J Pharmacol; 1990 Aug; 100(4):761-6. PubMed ID: 2119842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human prostanoid DP receptor stimulates mucin secretion in LS174T cells.
    Wright DH; Ford-Hutchinson AW; Chadee K; Metters KM
    Br J Pharmacol; 2000 Dec; 131(8):1537-45. PubMed ID: 11139429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory prostanoid EP receptors in human non-pregnant myometrium.
    Hillock CJ; Crankshaw DJ
    Eur J Pharmacol; 1999 Jul; 378(1):99-108. PubMed ID: 10478569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on ocular responses to DP receptor stimulation.
    Woodward DF; Spada CS; Hawley SB; Williams LS; Protzman CE; Nieves AL
    Eur J Pharmacol; 1993 Jan; 230(3):327-33. PubMed ID: 8440310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists.
    Crider JY; Griffin BW; Sharif NA
    Br J Pharmacol; 1999 May; 127(1):204-10. PubMed ID: 10369474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.
    Molderings GJ; Colling E; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1994 Mar; 111(3):733-8. PubMed ID: 8019753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium.
    Cao J; Shayibuzhati M; Tajima T; Kitazawa T; Taneike T
    Eur J Pharmacol; 2002 May; 442(1-2):115-23. PubMed ID: 12020689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the isoprostane, 8-epi-prostaglandin F2 alpha, on the contractility of the human myometrium in vitro.
    Crankshaw D
    Eur J Pharmacol; 1995 Oct; 285(2):151-8. PubMed ID: 8566133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
    Lydford SJ; McKechnie K
    Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor.
    Shiraishi Y; Asano K; Nakajima T; Oguma T; Suzuki Y; Shiomi T; Sayama K; Niimi K; Wakaki M; Kagyo J; Ikeda E; Hirai H; Yamaguchi K; Ishizaka A
    J Pharmacol Exp Ther; 2005 Mar; 312(3):954-60. PubMed ID: 15528449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues.
    Narumiya S; Toda N
    Br J Pharmacol; 1985 Jun; 85(2):367-75. PubMed ID: 2992661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.